TB PORTALS PROGRAM: DATA-DRIVEN MULTINATIONAL CONSORTIUM AGAINST DRUG-RESISTANT TUBERCULOSIS

Código QR

TB PORTALS PROGRAM: DATA-DRIVEN MULTINATIONAL CONSORTIUM AGAINST DRUG-RESISTANT TUBERCULOSIS

.

Guardado en:

Detalles Bibliográficos
Autores principales:	A. E. Gabrielian, A. Rosenthal
Formato:	article
Lenguaje:	RU
Publicado:	Sankt-Peterburg : NIIÈM imeni Pastera 2018
Materias:	Infectious and parasitic diseases RC109-216
Acceso en línea:	https://doaj.org/article/916993c529de4b7dba5a6f71825a150d
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares

GENOTYPING OF MULTIDRUG AND PREEXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS ISOLATES FROM A HIGH INCIDENCE TB AREA IN MOROCCO
por: I. Chaoui, et al.
Publicado: (2018)

The pipeline of new molecules and regimens against drug-resistant tuberculosis
por: Todd A. Black, et al.
Publicado: (2021)

Structure of Mycobacterium tuberculosis cytochrome bcc in complex with Q203 and TB47, two anti-TB drug candidates
por: Shan Zhou, et al.
Publicado: (2021)

ADVANCES IN THE STUDY OF MOLECULAR BASIS OF RESISTANCE TO NEW ANTI-TB DRUGS
por: I. V. Peretokina, et al.
Publicado: (2018)

Whole genome sequencing of clinical samples reveals extensively drug resistant tuberculosis (XDR TB) strains from the Beijing lineage in Nigeria, West Africa
por: Idowu B. Olawoye, et al.
Publicado: (2021)

The Role of the Tuberculosis (TB) Community in Detecting TB Suspects in Probolinggo Regency, East Java
por: Ro’isah, et al.
Publicado: (2021)

Siderite-based anaerobic iron cycle driven by autotrophic thermophilic microbial consortium
por: Daria G. Zavarzina, et al.
Publicado: (2020)

Activity of trifluoperazine against replicating, non-replicating and drug resistant M. tuberculosis.
por: Meeta J Advani, et al.
Publicado: (2012)

Antimicrobial activity of IDD-B40 against drug-resistant Mycobacterium tuberculosis
por: Md Imtiazul Islam, et al.
Publicado: (2021)

Adverse events in healthy individuals and MDR-TB contacts treated with anti-tuberculosis drugs potentially effective for preventing development of MDR-TB: a systematic review.
por: Miranda W Langendam, et al.
Publicado: (2013)

Capturing patient-reported and quality of life outcomes with use of shorter regimens for drug-resistant tuberculosis: mixed-methods substudy protocol, TB PRACTECAL-PRO
por: Bern-Thomas Nyang'wa, et al.
Publicado: (2021)

CHARACTERISTICS OF SECONDARY CASES OF TB FROM THE OUTBREAKS OF TUBERCULOSIS
por: Andrei CORLĂTEANU, et al.
Publicado: (2014)

A Multinational Analysis of Mutations and Heterogeneity in PZase, RpsA, and PanD Associated with Pyrazinamide Resistance in M/XDR Mycobacterium tuberculosis
por: S. M. Ramirez-Busby, et al.
Publicado: (2017)

What is the TB Burden in Nigerian Prisons? – An Enhanced TB Case Finding Program experience from 13 Nigerian Prisons
por: E. Onu, et al.
Publicado: (2017)

Multinational monitor
Publicado: (1980)

RESISTANCE PATTERNS IN PATIENTS OF DRUG RESISTANT PULMONARY TUBERCULOSIS
por: Yousaf Jamal, et al.
Publicado: (2019)

Childhood tuberculosis in household contacts of newly diagnosed TB patients.
por: Srichand Batra, et al.
Publicado: (2012)

Consortium Psychiatricum
Publicado: (2021)

Towards Innovation in Multinational Corporation Subsidiaries: Development of an Instrument to Select and Evaluate Value Driven Strategies
por: Corry,Sinead, et al.
Publicado: (2019)

PRODUCTION OF MYCOBACTERIUM TUBERCULOSIS TB10.4 RECOMBINANT PROTEIN IN ESCHERICHIA COLI
por: I. V. Dukhovlinov, et al.
Publicado: (2016)

Drug-Resistant Tuberculosis and HIV Infection: Current Perspectives
por: Singh A, et al.
Publicado: (2020)

Corrigendum: Risk of Introduction of Bovine Tuberculosis (TB) Into TB-Free Herds in Southern Bahia, Brazil, Associated With Movement of Live Cattle
por: Luciana N. Avila, et al.
Publicado: (2021)

Drug Resistance in Mycobacterium Tuberculosis Isolates to Isoniazid and Rifampin
por: M Pourhajibagher, et al.
Publicado: (2012)

Drug-resistant tuberculosis: emerging treatment options
por: Adhvaryu MR, et al.
Publicado: (2011)

Optima TB: A tool to help optimally allocate tuberculosis spending.
por: Lara Goscé, et al.
Publicado: (2021)

Community Members’ Perceptions of Tuberculosis (TB) Stigmatization in Rural Maharashtra, India
por: S. Tilekar, et al.
Publicado: (2017)

DETERMINANTS OF TB RELATED DEATH FROM TUBERCULOSIS PATIENTS IN THE NORTHERN THAILAND
por: R. Miyahara, et al.
Publicado: (2018)

DRUG RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS IN DIFFERENT LOCALIZATIONS OF THE DISEASE
por: P. K. Yablonskii, et al.
Publicado: (2016)

Nationalism and the Multinational State
por: Louay Safi
Publicado: (1992)

The emergence of Latin multinationals
por: Santiso, Javier
Publicado: (2014)

ANALYSIS OF SECONDARY RESISTANCE OF MYCOBACTERIUM TUBERCULOSIS TO SECOND-LINE ANTI-TUBERCULOSIS DRUGS IN CASABLANCA
por: G. Momen, et al.
Publicado: (2018)

Capturing variation impact on molecular interactions in the IMEx Consortium mutations data set
por: The IMEx Consortium Curators, et al.
Publicado: (2019)

The Genomic Standards Consortium.
por: Dawn Field, et al.
Publicado: (2011)

Viability of causative pathogen in patients with drug-sensitive and drug-resistant forms of respiratory tuberculosis
por: E. Yu. Zorkaltseva, et al.
Publicado: (2017)

Evaluating the Quality of Open Data Portals on the National Level
por: Máchová,Renata, et al.
Publicado: (2017)

GENOTYPES OF EXTENSIVELY DRUG-RESISTANT MYCOBACTERIUM TUBERCULOSIS STRAINS: CLINICAL AND EPIDEMIOLOGICAL FEATURES OF PULMONARY TUBERCULOSIS
por: N. R. Vasilieva, et al.
Publicado: (2016)

GENOTYPES OF MYCOBACTERIUM TUBERCULOSIS ISOLATES FROM DIFFERENT ORGANS OF PATIENTS WITH GENERALIZED TB AND HIV-COINFECTION
por: A. A. Gerasimova, et al.
Publicado: (2018)

Multi-Drug Resistance of Mycobacterium Tuberculosis – the Problem of Modern Phthisiology
por: E. Yu. Zorkaltseva, et al.
Publicado: (2019)

Treatment of tuberculosis in a region with high drug resistance: outcomes, drug resistance amplification and re-infection.
por: Maryline Bonnet, et al.
Publicado: (2011)

Predictors of Drug-Resistant Tuberculosis among High-Risk Population Diagnosed under National Program Conditions in the Littoral Region, Cameroon
por: Teyim Pride Mbuh, et al.
Publicado: (2021)